glp 1 brain inflammation GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential GLP-1 in the Hypothalamic Paraventricular

Made in the USA in a GMP-certified facility

Prescription rates of SGLT2 inhibitors and GLP-1 receptor agonists among adults with type 2 diabetes in the Veterans Health Administration varied by race, with white patients most likely to receive these medications

GLP-1 receptor agonist drugs like Ozempic slow emptying of the stomach and bowel, affecting colonoscopy and endoscopy prep.

Here we review published data from 24-h time-averaged HR monitoring in healthy individuals and subjects with type 2 diabetes mellitus (T2DM) treated with either short-acting GLP-1 RAs, lixisenatide or exenatide, or long-acting GLP-1 RAs, exenatide LAR, liraglutide, albiglutide, or dulaglutide (N = 1112

High fill rates of GLP-1 receptor agonist prescriptions in those with mood disorders could indicate that multimorbidity begets more treatment.